The Impact of Thrombocytopenia on Prognosis of HBV-related Small Hepatocellular Carcinoma: a Propensity Score Matching Analysis

Overview

Journal World J Surg Oncol

Publisher Biomed Central

Specialties General Surgery
Oncology

Date 2021 Feb 12

PMID 33573630

Citations 9

Authors

Wei Peng

Chuan Li

Xiaoyun Zhang

Tianfu Wen

Zheyu Chen

Affiliations

Soon will be listed here.

Abstract

Background: Thrombocytopenia was reported both detrimental and advantageous to hepatocellular carcinoma (HCC). However, there is little evidence showing clearly the clinical value of preoperative thrombocytopenia on the surgical outcome of patients with small HCC. This retrospective study aimed at elucidating the correlation between preoperative thrombocytopenia and surgical outcome of small HCC patients within Milan criteria treated with liver resection.

Methods: Data of hepatitis B virus (HBV)-related small HCC patients were retrospectively analyzed, and we performed the propensity score matching (PSM) analysis to overcome the imbalance of clinicopathological features. Patients enrolled were subsequently categorized into two groups according to preoperative platelet counts: thrombocytopenia group and non-thrombocytopenia group. Survival outcomes of the patients in both groups were described with the Kaplan-Meier method, and the difference was compared with a log-rank test. Cox regression analysis was applied to identify the risk factors of surgical outcome.

Results: After PSM, the estimated 1-, 3-, and 5-year overall survival (OS) rates for small HCC patients in the thrombocytopenia group were 94.5%, 77.0%, and 57.6%, and 95.0%, 79.6%, and 68.0%, respectively, for small HCC patients in the non-thrombocytopenia group (P = 0.042). And the 1-, 3-, and 5-year estimated recurrence-free survival (RFS) rates for small HCC patients in the thrombocytopenia group were 70.4%, 51.0%, and 42.1%, and 83.8%, 63.7%, and 46.7%, respectively, for small HCC patients in the non-thrombocytopenia group (P = 0.035). Multivariate analysis indicated preoperative thrombocytopenia was a significant prognosticator of poor RFS (hazard ratio (HR) = 1.388, 95% confidence interval (CI) 1.028~1.874, P = 0.033).

Conclusion: Preoperative thrombocytopenia had an undesirable impact on the recurrence of small HCC patients treated with liver resection.

Citing Articles

Prognostic value of thrombocytopenia during hospitalizations in intracerebral hemorrhage patients.

Feng H, Luo X, Fu A, Wang R, Qiao F Front Neurol. 2024; 15:1429988.

PMID: 39650240 PMC: 11620998. DOI: 10.3389/fneur.2024.1429988.

The Many Faces of Immune Thrombocytopenia: Mechanisms, Therapies, and Clinical Challenges in Oncological Patients.

Kos M, Tomaka P, Mertowska P, Mertowski S, Wojnicka J, Blazewicz A J Clin Med. 2024; 13(22).

PMID: 39597882 PMC: 11594473. DOI: 10.3390/jcm13226738.

Development and Validation of a Novel Prognostic Nomogram Based on Platelet and CD8T Cell Counts in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis.

Shi W, Yan H, Liu X, Yu L, Xie Y, Wu Y J Hepatocell Carcinoma. 2024; 11:1049-1063.

PMID: 38863997 PMC: 11166160. DOI: 10.2147/JHC.S452688.

Discontinuing Hepatitis Activity Reduced Hepatocellular Carcinoma Recurrence after Primary Curative Therapy.

Lee C, Shen C, Yen C, Yen T, Hsieh S J Pers Med. 2023; 13(3).

PMID: 36983579 PMC: 10052208. DOI: 10.3390/jpm13030397.

Deep-learning-based analysis of preoperative MRI predicts microvascular invasion and outcome in hepatocellular carcinoma.

Sun B, Gu P, Guan R, Zhou C, Lu J, Yang Z World J Surg Oncol. 2022; 20(1):189.

PMID: 35676669 PMC: 9178852. DOI: 10.1186/s12957-022-02645-8.

References

Scheiner B, Kirstein M, Popp S, Hucke F, Bota S, Rohr-Udilova N . Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma. Liver Cancer. 2019; 8(3):203-217. PMC: 6547277. DOI: 10.1159/000489833. View

Amano H, Tashiro H, Oshita A, Kobayashi T, Tanimoto Y, Kuroda S . Significance of platelet count in the outcomes of hepatectomized patients with hepatocellular carcinoma exceeding the Milan criteria. J Gastrointest Surg. 2011; 15(7):1173-81. DOI: 10.1007/s11605-011-1538-2. View

Giannini E, Botta F, Borro P, Malfatti F, Fumagalli A, Testa E . Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection. Am J Gastroenterol. 2003; 98(11):2516-20. DOI: 10.1111/j.1572-0241.2003.08665.x. View

Kang C, Choi G, Kim D, Choi S, Kim K, Choi J . Revisiting the role of nonanatomic resection of small (< or = 4 cm) and single hepatocellular carcinoma in patients with well-preserved liver function. J Surg Res. 2009; 160(1):81-9. DOI: 10.1016/j.jss.2009.01.021. View

Lee M, Chung G, Lee J, Oh S, Nam J, Chang Y . Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment. Hepatology. 2017; 66(5):1556-1569. DOI: 10.1002/hep.29318. View

Afdhal N, McHutchison J, Brown R, Jacobson I, Manns M, Poordad F . Thrombocytopenia associated with chronic liver disease. J Hepatol. 2008; 48(6):1000-7. DOI: 10.1016/j.jhep.2008.03.009. View

Hayashi H, Beppu T, Shirabe K, Maehara Y, Baba H . Management of thrombocytopenia due to liver cirrhosis: a review. World J Gastroenterol. 2014; 20(10):2595-605. PMC: 3949268. DOI: 10.3748/wjg.v20.i10.2595. View

Kaser A, Brandacher G, Steurer W, Kaser S, Offner F, Zoller H . Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood. 2001; 98(9):2720-5. DOI: 10.1182/blood.v98.9.2720. View

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

10.

Xue T, Ge N, Xu X, Le F, Zhang B, Wang Y . High platelet counts increase metastatic risk in huge hepatocellular carcinoma undergoing transarterial chemoembolization. Hepatol Res. 2016; 46(10):1028-36. DOI: 10.1111/hepr.12651. View

11.

Mehrabi A, Golriz M, Khajeh E, Ghamarnejad O, Probst P, Fonouni H . Meta-analysis of the prognostic role of perioperative platelet count in posthepatectomy liver failure and mortality. Br J Surg. 2018; 105(10):1254-1261. DOI: 10.1002/bjs.10906. View

12.

Wen T, Jin C, Facciorusso A, Donadon M, Han H, Mao Y . Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus. Hepatobiliary Surg Nutr. 2018; 7(5):353-371. PMC: 6230838. DOI: 10.21037/hbsn.2018.08.01. View

13.

Zheng J, Chou J, Gonen M, Vachharajani N, Chapman W, Doyle M . Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort. Ann Surg. 2017; 266(4):693-701. PMC: 8404085. DOI: 10.1097/SLA.0000000000002360. View

14.

Tao Y, Li Y, Liu X, Deng Q, Yu Y, Yang Z . Nonsteroidal anti-inflammatory drugs, especially aspirin, are linked to lower risk and better survival of hepatocellular carcinoma: a meta-analysis. Cancer Manag Res. 2018; 10:2695-2709. PMC: 6101020. DOI: 10.2147/CMAR.S167560. View

15.

Iannacone M, Sitia G, Narvaiza I, Ruggeri Z, Guidotti L . Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus. Clin Vaccine Immunol. 2007; 14(11):1532-5. PMC: 2168169. DOI: 10.1128/CVI.00298-07. View

16.

Lee P, Yeh C, Hu Y, Chen C, Liu C, Su C . Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection. Ann Surg Oncol. 2016; 23(Suppl 5):874-883. DOI: 10.1245/s10434-016-5520-9. View

17.

Cheng Y, Wang K, Zhang X, Wei X, Jiang Y, Hu Y . Thrombocytopenia: A prognostic factor for hepatocellular carcinoma patients with portal vein tumor thrombus after hepatectomy. J Gastroenterol Hepatol. 2018; 34(7):1214-1221. DOI: 10.1111/jgh.14537. View

18.

Wang Y, Kang J, Zhi Y, Zhang Y, Wang Z, Zhou Q . The pretreatment thrombocytosis as one of prognostic factors for gastric cancer: A systematic review and meta-analysis. Int J Surg. 2018; 53:304-311. DOI: 10.1016/j.ijsu.2018.03.084. View

19.

Bihari C, Rastogi A, Shasthry S, Bajpai M, Bhadoria A, Rajesh S . Platelets contribute to growth and metastasis in hepatocellular carcinoma. APMIS. 2016; 124(9):776-86. DOI: 10.1111/apm.12574. View

20.

Roayaie S, Obeidat K, Sposito C, Mariani L, Bhoori S, Pellegrinelli A . Resection of hepatocellular cancer ≤2 cm: results from two Western centers. Hepatology. 2012; 57(4):1426-35. PMC: 3442120. DOI: 10.1002/hep.25832. View